Pacritinib
Showing 26 - 33 of 33
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic Trial in Ann Arbor, Rochester (Pacritinib, Ibrutinib)
Withdrawn
- Chronic Lymphocytic Leukemia
- Lymphoma, Small Lymphocytic
- Pacritinib
- Ibrutinib
-
Ann Arbor, Michigan
- +1 more
Sep 5, 2017
Colorectal Cancer Trial in Saint Louis (Pacritinib)
Terminated
- Colorectal Cancer
- Pacritinib
-
Saint Louis, MissouriWashington University School of Medicine
Apr 27, 2017
Chronic Myelomonocytic Leukemia, Juvenile Myelomonocytic Leukemia, Atypical Chronic Myeloid Leukemia Trial (Pacritinib,
Withdrawn
- Chronic Myelomonocytic Leukemia
- +5 more
- Pacritinib
- Decitabine
- (no location specified)
May 3, 2017
Healthy Trial in Evansville (Treatment A: 400 mg Pacritinib P3CT, Treatment B: 400 mg of pacritinib FMI)
Completed
- Healthy
- Treatment A: 400 mg Pacritinib P3CT
- Treatment B: 400 mg of pacritinib FMI
-
Evansville, IndianaCovance Clinical Research Unit Inc.
Jun 30, 2016
Healthy Subjects Trial in Daytona Beach (Pacritinib 400 mg Capsule (Treatment A), Pacritinib 80 mg Solution (Treatment B))
Completed
- Healthy Subjects
- Pacritinib 400 mg Capsule (Treatment A)
- Pacritinib 80 mg Solution (Treatment B)
-
Daytona Beach, FloridaCovance Clinical Research Unit
Jun 16, 2016
Healthy Subjects Trial in Daytona Beach (Pacritinib, Rifampin, Pacritinib and Rifampin)
Completed
- Healthy Subjects
- Pacritinib
- +2 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Jun 20, 2016
Healthy Subjects Trial in Evansville (A: 400 mg pacritinib, B: Placebo, C: 400 mg moxifloxacin)
Completed
- Healthy Subjects
- A: 400 mg pacritinib
- +2 more
-
Evansville, IndianaCovance Clinical Research Unit Inc.
Jun 16, 2016
Healthy Trial in Groningen (Pacritinib)
Completed
- Healthy
- Pacritinib
-
Groningen, NetherlandsQPS Netherlands B.V.
Jun 14, 2016